PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.27M | 50.39M | 52.99M | 46.97M | 37.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.27M | 50.39M | 52.99M | 46.97M | 37.72M |
| Cost of Revenue | 38.42M | 38.59M | 40.27M | 35.83M | 28.41M |
| Gross Profit | 11.85M | 11.80M | 12.72M | 11.13M | 9.31M |
| SG&A Expenses | 9.49M | 10.31M | 9.74M | 8.82M | 7.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.98M | 50.12M | 51.10M | 45.58M | 36.78M |
| Operating Income | 1.29M | 264.00K | 1.89M | 1.39M | 937.60K |
| Income Before Tax | 1.26M | 220.30K | 1.92M | 1.46M | 938.00K |
| Income Tax Expenses | 213.70K | -183.60K | 396.30K | 120.50K | 75.90K |
| Earnings from Continuing Operations | 1.05 | 0.40 | 1.53 | 1.34 | 0.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.05M | 404.00K | 1.53M | 1.34M | 862.00K |
| EBIT | 1.29M | 264.00K | 1.89M | 1.39M | 937.60K |
| EBITDA | 2.10M | 1.22M | 2.70M | 2.01M | 1.43M |
| EPS Basic | 0.05 | 0.02 | 0.08 | 0.07 | 0.04 |
| Normalized Basic EPS | 0.04 | 0.01 | 0.07 | 0.05 | 0.03 |
| EPS Diluted | 0.05 | 0.02 | 0.08 | 0.07 | 0.04 |
| Normalized Diluted EPS | 0.04 | 0.01 | 0.07 | 0.05 | 0.03 |
| Average Basic Shares Outstanding | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
| Average Diluted Shares Outstanding | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |